Idorsia Ltd
Idorsia Ltd (IDRSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IDRSF · as of Jun 9, 2026
Key Statistics
Explore Idorsia Ltd Data
idrsf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
idrsf competitorsIDRSF
ARRJF
ASCLF
BPMUF
INRLF
LFTSFStock Performance
Full HistoryAbout Idorsia Ltd
Idorsia Ltd Established in 2017 and based in Allschwil, Switzerland, Idorsia Ltd operates as a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address sig…
what is idorsia ltd · idrsf stock overview · idorsia ltd company profile · who is idorsia ltd ceo · idrsf OTC · idorsia ltd headquarters · idorsia ltd business segments
About Stock Overview & Key Data
Idorsia Ltd (IDRSF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 17, 2017. As of the latest trading session, IDRSF stock price is $5.75, with a market capitalization of $1.5B. The stock has returned +209.14% over the past 12 months and +9.52% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Idorsia Ltd stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Idorsia Ltd reported revenue of $221.1M and net income of -$112.1M. For detailed data — including Idorsia Ltd revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Idorsia Ltd (IDRSF) stock price is $5.75. The stock is traded on OTC under the ticker symbol IDRSF. The 52-week range is $1.86 – $5.82.